Author:

Keywords:

Aged, Antihypertensive Agents, Blood Pressure, Clinical Trials as Topic, Drug Costs, Drug Prescriptions, Forecasting, Humans, Hypertension, Meta-Analysis as Topic, Middle Aged, Risk Factors, Treatment Outcome, Science & Technology, Life Sciences & Biomedicine, Cardiac & Cardiovascular Systems, Cardiovascular System & Cardiology, cardiovascular complications, coronary heart disease, hypertension, stroke, ISOLATED SYSTOLIC HYPERTENSION, CONVERTING-ENZYME-INHIBITION, CALCIUM-CHANNEL BLOCKADE, END-POINT REDUCTION, RANDOMIZED-TRIAL, CARDIOVASCULAR MORBIDITY, MYOCARDIAL-INFARCTION, OLDER PATIENTS, ANTIHYPERTENSIVE TREATMENT, LOSARTAN INTERVENTION, 1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, Cardiovascular System & Hematology, 3201 Cardiovascular medicine and haematology, 3202 Clinical sciences